Greenberg Traurig’s Joseph F. Coniglio to Present at the 27th Annual Course on Advanced Medical Torts

Cassin & Cassin LLP Welcomes New Attorneys and Expands Client Service Offerings

Joseph F. Coniglio, managing partner of the global law firm Greenberg Traurig, LLP’s Dallas office, will speak about advanced medical treatments on March 25 at 3:00 p.m. CT on the virtual 27th year course.

DALLAS, March 23, 2021 / PRNewswire-PRWeb / – Joseph F. Rabbit, managing partner of the global law firm Greenberg Traurig, LLP Dallas Office, will talk about Advanced Medical Torts on the virtual 27th year course 25th March at the 3:00 p.m. CT.

Coniglio’s presentation will analyze the “Piercing of the Corporate Veil” liability theory as well as the “Alter Ego” doctrine that has implications Texas Healthcare companies. He will elaborate on the factors considered by Texas Courts in evaluating corporate veil piercing and the legal requirements and restrictions as set out in the Texas Business Organizations Code. Coniglio will present alongside the lawyer Michael Sawicki.

“I am honored to have the opportunity to speak to my colleagues in the Texas Bar about advanced medical issues during the annual class,” said Coniglio. “The event has been a premier conference over the years for those involved in healthcare litigation, providing attendees with relevant content and timely updates in this complex area.”

The conference is hosted by the Texas Bar Continuing Legal Education (CLE) program and offers 11.75 hours of credit (including 3 hours of ethics). Texas Bar CLE is regulated by the MCLE division.

Coniglio is a shareholder in the Health Care & FDA Practice. He has extensive experience in health law and complex commercial disputes. He uses his 20+ years of experience in the healthcare industry to serve a wide variety of healthcare facilities and providers including hospitals, medical groups and long-term care facilities, as well as clinical laboratories and pharmacies in litigation and regulatory matters.

Greenberg Traurig Health and FDA Practice Information: Greenberg Traurig’s multidisciplinary health and FDA practice provides strategic advice to a diverse group of companies and other organizations and helps them proactively respond to the rapidly changing healthcare market. The group combines dedicated healthcare and operational compliance experience with corporate and securities, finance, tax, antitrust, ERISA, commercial and government litigation, restructuring, intellectual property and biotechnology skills a wide range of requirements to meet legal advice.

The story goes on

About Greenberg Traurig, LLP – Texas:: Texas is important to Greenberg Traurig, LLP and part of its history. With approximately 130 Texan lawyers in Austin, Dallas, and Houston, Greenberg Sad has deep roots in the Texas Business, legal and government communities. Greenberg Sad Texas works with clients to meet their interdisciplinary legal needs across the state using the company’s global platform. The Texas The attorneys have experience in industries vital to the future of the state including aerospace, chemistry, construction, education, energy and natural resources, financial institutions, healthcare, hedge funds, hospitality, infrastructure, insurance, media, medical devices, pharmaceuticals and biotechnology. Real estate, retail, sports, technology and software, telecommunications, transportation, and video games and esports.

About Greenberg Traurig: Greenberg Traurig, LLP (GT), has approximately 2200 attorneys in 40 locations in The United States, Latin America, Europe, Asia, and the middle East. Recognized for its philanthropic giving, diversity, and innovation, GT is consistently ranked among the largest companies in the United States for the Law360 400 and the top 20 for the Am Law Global 100. The company is ranked for being Act climate-neutral office energy consumption and Mansfield Rule 3.0 certified. Web:

Media contact

Lourdes Brezo Martinez, Greenberg Traurig, LLP, +1 212.801.2131, [email protected]

SOURCE Greenberg Sad, LLP